| Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992) |
|---|
| 01/12/2006 | WO2005047480A3 Delta-15 desaturases suitable for altering levels of polyunsaturated fatty acids in oleaginous plants and yeast |
| 01/12/2006 | WO2005035731A3 Methods for treating diseases and conditions with inverse agonists and for screening for agents acting as inverse agonists |
| 01/12/2006 | WO2005021718A3 Tubulin regulatory elements for use in plants |
| 01/12/2006 | WO2005017128A3 Improved reagents for recombinogenic engineering and uses thereof |
| 01/12/2006 | WO2005012486A3 Metabolically engineered bacterial strains having enhanced 2-keto-d-gluconate accumulation |
| 01/12/2006 | WO2005003303A3 Nadks as modifiers of branching morphogenesis and methods of use |
| 01/12/2006 | WO2004111199A3 Systems and methods for treating human inflammatory and proliferative diseases and wounds, with fatty acid metabolism inhibitors and/or glycolytic inhibitors |
| 01/12/2006 | WO2004106495A3 Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer |
| 01/12/2006 | WO2004090108A3 Irna conjugates |
| 01/12/2006 | WO2004087882A3 Neuregulin protein regulation of synaptic proteins |
| 01/12/2006 | WO2004081194A3 Approaches to identifying genetic traits in animals |
| 01/12/2006 | WO2004081184A3 Markerless transformation |
| 01/12/2006 | WO2004067720A3 Systems and methods for predicting specific genetic loci that affect phenotypic traits |
| 01/12/2006 | US20060009409 Double-stranded oligonucleotides |
| 01/12/2006 | US20060008883 Using vector transformation to generate protein fusions with reduced immunogenicity; directed protein evolution |
| 01/12/2006 | US20060008815 Compositions, methods, and systems for inferring canine breeds for genetic traits and verifying parentage of canine animals |
| 01/11/2006 | EP1614426A1 Attenuated strains of vibrio cholerae and lyophilised vaccines containing same |
| 01/11/2006 | EP1613961A2 Surface receptor complexes as biomarkers |
| 01/11/2006 | EP1613775A2 Selected rna motifs to include cell death and/or apoptosis |
| 01/11/2006 | EP1613737A2 Artificial receptors including reversibly immobilized building blocks and methods |
| 01/11/2006 | EP1613736A2 Inhibition of viral pathogenesis |
| 01/11/2006 | EP1613735A2 Expanding the eukaryotic genetic code |
| 01/11/2006 | EP1613734A2 Visualizing expression data on chromosomal graphic schemes |
| 01/11/2006 | EP1613733A2 Pectate lyases, nucleic acids encoding them and methods for making and using them |
| 01/11/2006 | EP1613732A2 Intracellular complexes as biomarkers |
| 01/11/2006 | EP1613727A2 Approaches to identifying genetic traits in animals |
| 01/11/2006 | EP1613725A2 Altered fad2 and fad3 genes in brassica and the molecular marker-assisted detection thereof |
| 01/11/2006 | EP1613723A2 Fragmentation-based methods and systems for sequence variation detection and discovery |
| 01/11/2006 | EP1613642A2 Staphylococcus aureus efb protein and c3 binding region which inhibit complement activation |
| 01/11/2006 | EP1613348A2 Methods for modulating angiogenesis with apelin compositions |
| 01/11/2006 | EP1613318A2 Compounds and their use to treat diabetes and related disorders |
| 01/11/2006 | EP1613205A2 Erbb surface receptor complexes as biomarkers |
| 01/11/2006 | EP0787142B1 Neurturin and related growth factors |
| 01/05/2006 | WO2005059107A3 Chemokine receptor binding compounds |
| 01/05/2006 | WO2005049799A3 Chimeric chemokine receptor polypeptides |
| 01/05/2006 | WO2005040350A3 Compositions, methods, and systems for inferring canine breeds for genetic traits and verifying parentage of canine animals |
| 01/05/2006 | WO2005017114A3 Method of increasing metabolism and stress tolerance in a plant |
| 01/05/2006 | WO2005005597A3 Novel mouse polypeptides encode by polynucleotides and methods of their use |
| 01/05/2006 | WO2004108887A3 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors |
| 01/05/2006 | US20060003404 Method for specific integration of t7 rna polymerase gene in the chromosome of corynebacterial and the resultant corynebacteria-t7 promoter based shuttle vector system |
| 01/05/2006 | US20060003322 a nucleotide sequence of a first half of said RNA precursor is a partial inversed-reversed sequence of a nucleotide sequence of a second half |
| 01/05/2006 | US20060002919 15625 receptor, a novel G-protein coupled receptor |
| 01/04/2006 | EP1612272A2 Novel antiangiogenic peptides, polynucleotides encoding same and methods for inhibiting angiogenesis |
| 01/04/2006 | EP1611240A2 Interacts with ice1 and regulates cbf expression and freezing tolerance in arabidopsis |
| 01/04/2006 | EP1610802A2 Parkin interacting polypeptides and methods of use |
| 01/04/2006 | CN1717585A Inferring gene regulatory networks from time-ordered gene expression data using differential equations |
| 01/04/2006 | CN1715413A Corynebacterium glutamicum genes encoding metabolic pathway proteins |
| 12/29/2005 | WO2005049806A3 Novel nucleic acids and polypeptides |
| 12/29/2005 | WO2005049790A3 Skn-1 and gsk-3 genes and proteins |
| 12/29/2005 | WO2005042706A3 Ephx2 genetic markers associated with galantamine response |
| 12/29/2005 | WO2005042698A3 T cell epitopes useful in a hepatitis c virus vaccine and as diagnostic tools and methods for identifying same |
| 12/29/2005 | WO2005037990A3 Use of parp inhibitors for prevention and treatment of diabetic and insulin resistance complications |
| 12/29/2005 | WO2005026319A3 Erythrocytic cells and method for loading solutes |
| 12/29/2005 | WO2005023996A3 METHODS OF INDUCING THE EXPRESSION OF BONE MORPHOGENETIC PROTEINS (BMPs) AND TRANSFORMING GROWTH FACTOR-β PROTEINS (TGF-βs) IN CELLS |
| 12/29/2005 | WO2005010159A3 Rolling circle amplification of micro-rna samples |
| 12/29/2005 | WO2005001043A3 METHODS AND COMPOSITIONS FOR ENHANCING THE EFFICACY AND SPECIFICITY OF FNAi |
| 12/29/2005 | WO2004101745A3 NOVEL REGULATORY MECHANISMS OF NF-kappaB |
| 12/29/2005 | WO2004094599A3 Disease prevention and vaccination following thymic reactivation |
| 12/29/2005 | WO2004091384A3 Erbb surface receptor complexes as biomarkers |
| 12/29/2005 | WO2004074437A3 Compositions and methods for cancer immunotherapy |
| 12/29/2005 | WO2003033671A3 Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions |
| 12/29/2005 | US20050289660 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |
| 12/29/2005 | US20050287585 In situ synthesis of oligonucleotide fragments on a solid phase microarray platform and subsequent, "on device" assembly of larger polynucleotides composed of shorter oligonucleotide fragments |
| 12/29/2005 | US20050287532 Methods for monitoring drug activities in vivo |
| 12/28/2005 | EP1609107A2 Methods of identifying optimal variants of peptide epitopes |
| 12/28/2005 | EP1608970A2 Ccn3 compositions and methods |
| 12/28/2005 | EP1608969A2 Separation and accumulation of subcellar components, and proteins derived therefrom |
| 12/28/2005 | EP1608782A2 Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof |
| 12/28/2005 | EP1608776A2 Methods for monitoring drug activities in vivo |
| 12/28/2005 | EP1608755A2 Tak1-mediated inhibition of osteogenesis |
| 12/28/2005 | EP1608736A2 Polynucleotide encoding a novel trp channel family member, ltrpc3, and splice variants thereof |
| 12/28/2005 | EP1608735A2 Irna conjugates |
| 12/28/2005 | EP1608732A2 Compositions and methods of using a synthetic dnase i |
| 12/28/2005 | EP1608730A2 Truncated baff receptors |
| 12/28/2005 | EP1608411A2 Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure and renal dysfunction |
| 12/28/2005 | CN1714152A Aspartyl protease inhibitor as a nematode allergen |
| 12/27/2005 | US6979726 Immunoconjugates |
| 12/27/2005 | US6979560 Eschericha bacteria overexpressing the yahn gene for feedback-insensitive amino acid production |
| 12/22/2005 | WO2005052116A3 Preservative-containing virus formulations |
| 12/22/2005 | WO2005033269A3 Methods for inducing an immune response via oral administration of an adenovirus |
| 12/22/2005 | WO2005021705A8 Citrus sesquiterpene synthase, methods of production and uses thereof |
| 12/22/2005 | WO2005012482B1 Assay for identification of bioactive compounds that interact with heat shock protein 90 |
| 12/22/2005 | WO2005002418A3 Mptens as modifiers of the pten/igf pathway and methods of use |
| 12/22/2005 | WO2005001030A3 Markers for pre-cancer and cancer cells and the method to interfere with cell proliferation therein |
| 12/22/2005 | WO2004111191A3 Methods and compositions for controlling efficacy of rna silencing |
| 12/22/2005 | WO2004108903A8 Plant transformation and selection |
| 12/22/2005 | WO2004104181A3 Nucleic acid processing methods, kits and devices |
| 12/22/2005 | WO2004104179A3 Method for isolating and cloning high molecular weight polynucleotide molecules from the environment |
| 12/22/2005 | WO2004094613A3 Polyvalent protein complex |
| 12/22/2005 | WO2004087874A3 Novel nucleic acids and polypeptides |
| 12/22/2005 | WO2004085623A3 A compact synthetic expression vector comprising double-stranded dna molecules and methods of use thereof |
| 12/22/2005 | WO2004078948A3 METHOD TO IDENTIFY REGULATORS OF CELLULAR ACTIVATION USING Bcl10 |
| 12/22/2005 | WO2004076637A3 Cell-polymer fiber compositions and use thereof |
| 12/22/2005 | WO2004072241A3 Compositions and methods for cleaving iap |
| 12/22/2005 | WO2004070004A3 Rat receptor tyrosine kinase, kdr |
| 12/22/2005 | US20050283844 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 12/22/2005 | US20050283211 Photomodulation methods and devices for regulating cell proliferation and gene expression |
| 12/22/2005 | US20050282761 Modulation of growth hormone receptor expression and insulin-like growth factor expression |
| 12/22/2005 | US20050282222 Nematode PAN and ZP receptor-like sequences |
| 12/22/2005 | US20050281829 Fc chimeric proteins with anti-HIV drugs |